Prediction of intestinal absorption: Comparative assessment of GASTROPLUS™ and IDEA™

European Journal of Pharmaceutical Sciences

Volumn 17, Issue 1-2, 2002, Pages 51-61

  Parrott, Neil ^a   Lavé, Thierry ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

ADME; Modeling; Oral absorption; Physiologically based pharmacokinetics; Simulation

Indexed keywords

ABSORPTION; FORECASTING; PHYSIOLOGICAL MODELS;

DRUG DISCOVERY;

DRUG PRODUCTS;

ACICLOVIR; AMILORIDE; ATENOLOL; CARBAMAZEPINE; CHLORAMPHENICOL; DESIPRAMINE; DIAZEPAM; DILTIAZEM; ETOPOSIDE; FUROSEMIDE; GANCICLOVIR; HYDROCHLOROTHIAZIDE; KETOPROFEN; METOPROLOL; NAPROXEN; PENICILLIN V; PHENAZONE; PIRENZEPINE; PIROXICAM; PROGESTERONE; PROPRANOLOL; RANITIDINE; SAQUINAVIR; SULPIRIDE; TERBUTALINE; THEOPHYLLINE; VERAPAMIL; WARFARIN;

ANALYTIC METHOD; ARTICLE; CELL LINE; COLON CARCINOMA; COMPUTER MODEL; COMPUTER PROGRAM; DIAGNOSTIC PROCEDURE; DRUG ABSORPTION; DRUG SOLUBILITY; INTERMETHOD COMPARISON; INTERNET; INTESTINE ABSORPTION; PREDICTION; PRIORITY JOURNAL; THERMODYNAMICS;

INTESTINAL ABSORPTION; PHARMACEUTICAL PREPARATIONS; PREDICTIVE VALUE OF TESTS; SOFTWARE;

EID: 0036803219     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-0987(02)00132-X     Document Type: Article

References (15)

1. Agoram B., Woltosz W.S., Bolger M.B. Predicting the impact of physiological and biochemical processes on oral drug bioavailability. Adv. Drug Deliv. Rev. 50:(Suppl. 1):2001;S41-S67.
2. Artursson P., Palm K., Luthman K. Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv. Drug Deliv. Rev. 22:1996;67-84.
3. Dollery C. Therapeutic Drugs. 2nd Edition:1998;Churchill Livingstone.
4. Goodman, L.S.O.G., A (Orig); Hardman, J.G. Limbird, L.E. Molinoft, P.B. Ruddon, R.W., 1999. Goodman and Gilman's The Pharmacological Basis of Therapeutics.
5. Grass G.M. Simulation models to predict oral drug absorption from in vitro data. Adv. Drug Deliv. Rev. 23:1997;190-219.
6. Grass G.M., Sinko P.J. Physiologically-based pharmacokinetic simulation modelling. Adv. Drug Deliv. Rev. 54:(3):2002;433-451.
7. Leesman G., Norris D., Timony G., Chen Y., Pirson W., Theil F.P., Schmitt-Hoffman A.H., Lee Y.H., Doerr-Stevens J., Gordon P., Retajczyk R., Tran S., Lee K.-J., Johnson N., Castelo J., Christopher R., Grass G., Sinko P. Assessment of the physiologically-based IDEA™ predictive model using an external (blinded) data set. Poster presented at the AAPS 2000:2000.
8. LION Bioscience, W.S., 69123 Heidelberg, Germany. http://www.lionbioscience.com/ .
9. Lipinski C., Lombardo F., Dominy B., Feeney P. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 23:1997;3-25.
10. Norris D.A., Leesman G.D., Sinko P.J., Grass G.M. Development of predictive pharmacokinetic simulation models for drug discovery. J. Controlled Release. 65:2000;55-62.
11. Prentis R.A., Lis Y., Walker S.R. Pharmaceutical innovation by the seven UK-owned pharmaceutical companies (1964-1985). Br. J. Clin. Pharmacol. 25:1988;387-396.
12. Vergin H.M.H., Strobel K., Nitsche V. Pharmacokinetics and bioequivalence of different formulations of pirenzepine Arzneimittel-Forschung. 36:(9):1986;1409-1412.
13. Wessel M.D., Jurs P.C., Tolan J.W., Muskal S.M. Prediction of human intestinal absorption of drug compounds from molecular structure. J. Chem. Inf. Comp. Sci. 38:1998;726-735.
14. Yu L.X., Crison J.R., Amidon G.L. Compartmental transit and dispersion model analysis of small intestinal transit flow in humans. Int. J. Pharmaceut. 140:1996;111-118.
15. Zhao Y.H., Le J., Abraham M.H., Hersey A., Eddershaw P.J., Luscombe C.N., Boutina D., Beck G., Sherborne B., Cooper I. Evaluation of human intestinal absorption data and subsequent derivation of a quantitative structure activity relationship (QSAR) with the Abraham descriptors. J. Pharm. Sci. 90:(6):2001;749-784.